Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
Ohio State University Comprehensive Cancer Center National Cancer Institute (NCI) |
---|---|
Information provided by: | Ohio State University Comprehensive Cancer Center |
ClinicalTrials.gov Identifier: | NCT00201851 |
This trial tests surgical oophorectomy (removal of ovaries) plus Tamoxifen, done at different times in the menstrual cycle, as adjuvant therapy for invasive breast cancer in 510 premenopausal women with Hormone Receptor-positive Breast Cancer. This study is recruiting at hospitals in Philippines, Vietnam, and Morocco.
Condition | Intervention | Phase |
---|---|---|
Breast Cancer |
Drug: Tamoxifen Procedure: Surgery: Oophorectomy |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Uncontrolled, Parallel Assignment, Efficacy Study |
Official Title: | Phase III Randomized Study of Immediate Versus Luteal Phase Adjuvant Oophorectomy and Tamoxifen in Premenopausal Women With Hormone Receptor-Positive Breast Cancer |
Ages Eligible for Study: | 18 Years to 50 Years |
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Morocco | |
National Institute of Oncology | |
Rabat, Morocco | |
Philippines | |
Vicente Soto Memorial Medical Center | |
Cebu, Philippines | |
Philippine General Hospital | |
Manila, Philippines | |
East Avenue Medical Center | |
Manila, Philippines | |
Rizal | |
Manila, Philippines | |
Santo Toma Hospital | |
Manila, Philippines | |
Vietnam | |
Hospital K, National Cancer Institute | |
Hanoi, Vietnam | |
Danang General | |
Danang, Vietnam | |
Hue Central | |
Hue, Vietnam |
Principal Investigator: | Richard R. Love, M.D. | Ohio State University |
Study ID Numbers: | OSU-0483 |
Study First Received: | September 12, 2005 |
Last Updated: | December 26, 2006 |
ClinicalTrials.gov Identifier: | NCT00201851 History of Changes |
Health Authority: | United States: Food and Drug Administration |
Asian Premenopausal Women Oophorectomy |
Estrogen Antagonists Estrogens Skin Diseases Antineoplastic Agents, Hormonal Hormone Antagonists Adjuvants, Immunologic Hormones, Hormone Substitutes, and Hormone Antagonists |
Breast Neoplasms Bone Density Conservation Agents Selective Estrogen Receptor Modulators Tamoxifen Hormones Estrogen Receptor Modulators Breast Diseases |
Estrogen Antagonists Skin Diseases Antineoplastic Agents, Hormonal Antineoplastic Agents Hormone Antagonists Physiological Effects of Drugs Hormones, Hormone Substitutes, and Hormone Antagonists Breast Neoplasms Bone Density Conservation Agents |
Selective Estrogen Receptor Modulators Tamoxifen Pharmacologic Actions Estrogen Receptor Modulators Neoplasms Neoplasms by Site Therapeutic Uses Breast Diseases |